EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Rectal Indomethacin in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Meta-Analysis with Trial Sequential Analysis

Bisher Sawaf, Qasi Najah, Mohammad Badr Almoshantaf, Mulham Alom, Yusuf Omar Hallak, Mhd Kutaiba Albuni, Muhammed Elhadi, Yaseen Alastal

Digestive Diseases · 2025

DOI: 10.1159/000548343 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Digestive Diseases, 2025. Verfasst von Bisher Sawaf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The University of Toledo, Toledo, Ohio, USA. Hauptthemen laut MEDLINE: Indomethacin, Pancreatitis, Cholangiopancreatography, Endoscopic Retrograde, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute pancreatitis is a significant complication of endoscopic retrograde cholangiopancreatography (ERCP) with no established prevention strategy. Recent studies suggest that rectal indomethacin may reduce the incidence of post-ERCP pancreatitis (PEP), but its effectiveness varies with patient risk levels and the concurrent use of pancreatic stenting. This updated meta-analysis evaluates the efficacy of rectal indomethacin in preventing PEP.

Methods

A systematic search of PubMed, Embase, and Scopus up to April 2025 identified randomized controlled trials (RCTs) comparing rectal indomethacin with placebo for PEP prevention. Random-effects meta-analysis, meta-regression, and subgroup analysis were conducted using the R Meta package v8.0–2. Cochrane’s ROB2 and Egger’s regression test are used to assess the risk of bias.

Results

The analysis included 15 RCTs representing a total of 4,962 patients. Rectal indomethacin significantly reduced the incidence of PEP compared to placebo (risk ratio [RR]: 0.58; 95% confidence interval [CI], 0.45–0.73; p < 0.01) with no increased risk for bleeding complications (RR: 0.95, 95% CI: 0.64–1.41, p = 0.76). Subgroup analysis showed that indomethacin was effective, especially when given concurrently with a pancreatic stent (RR: 0.4539, 95% CI: 0.26–0.79). However, a high risk of bias was observed in nearly 25% of the overall assessment; there was evidence of a small-study effect, as suggested by Egger’s regression test (p < 0.01).

Conclusion

Prophylactic rectal indomethacin appears to be effective in preventing PEP, with no increased risk for bleeding. Future studies should focus on combining other prophylactic options to achieve better prevention of PEP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndomethacinPancreatitisCholangiopancreatography, Endoscopic RetrogradeAnti-Inflammatory Agents, Non-SteroidalHumansAdministration, RectalRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

IndomethacinMeta-analysisPost-endoscopic retrograde cholangiopancreatography pancreatitis

Substanzen

IndomethacinAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Internal Medicine, The University of Toledo, Toledo, Ohio, USA.
  • Faculty of Medicine, Elmergib University, Alkhums, Libya.
  • London North West Healthcare NHS Trust, London, UK.
  • Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
  • Department of Internal Medicine, TriHealth Inc., Cincinnati, Ohio, USA.
  • College of Medicine, Korea University, Seoul, Republic of Korea.

Zitieren

APA

Sawaf, B., Najah, Q., Almoshantaf, M. B., Alom, M., Hallak, Y. O., Albuni, M. K., Elhadi, M., & Alastal, Y. (2025). Rectal Indomethacin in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Meta-Analysis with Trial Sequential Analysis. Digestive Diseases. https://doi.org/10.1159/000548343

Vancouver

Sawaf B, Najah Q, Almoshantaf MB, Alom M, Hallak YO, Albuni MK, et al. Rectal Indomethacin in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Meta-Analysis with Trial Sequential Analysis. Digestive Diseases. 2025. doi:10.1159/000548343

BibTeX
@article{Sawaf2025,
  author = {Sawaf, Bisher and Najah, Qasi and Almoshantaf, Mohammad Badr and Alom, Mulham and Hallak, Yusuf Omar and Albuni, Mhd Kutaiba and Elhadi, Muhammed and Alastal, Yaseen},
  title = {Rectal Indomethacin in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Meta-Analysis with Trial Sequential Analysis},
  journal = {Digestive Diseases},
  year = {2025},
  doi = {10.1159/000548343}
}
Kostenlos starten →